Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01410136 · ClinicalTrials.gov registry record · NA
Chondrofix Osteochondral Allograft Prospective Study
A NA study, sponsored by Zimmer Orthobiologics.
- Terminated
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT01410136 is a NA study that was terminated before completion, run by Zimmer Orthobiologics. The registered enrollment target is 29 participants.
The verdict
NCT01410136, a NA study, was terminated before completion, sponsored by Zimmer Orthobiologics.
- TERMINATED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
The overall study objective is to evaluate Chondrofix Osteochondral Allograft ("Chondrofix") for the repair of osteochondral lesions in the knee. This includes, but is not limited to primary cartilage lesion repair and revision of failed prior cartilage repair treatments. The study hypothesis is that Chondrofix Allograft will provide pain relief and functional improvement as demonstrated by a comparative analysis of baseline clinical evaluations at 24 months of follow-up.
Interventions
- PROCEDURE Chondrofix Osteochondral Allograft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2011-04 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01410136
The ClinicalTrials.gov registry entry for NCT01410136 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Orthobiologics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chondrofix Osteochondral Allograft is the first listed.
NCT01410136 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01410136 about?
NCT01410136 is a clinical study titled "Chondrofix Osteochondral Allograft Prospective Study". The overall study objective is to evaluate Chondrofix Osteochondral Allograft ("Chondrofix") for the repair of osteochondral lesions in the knee. This includes, but is not limited to primary cartilage lesion repair and revision of failed prior cartilage repair treatments. The study hypothesis is tha...
What is the current status of trial NCT01410136?
This trial is currently terminated. It is a NA study. The enrollment target is 29 participants. The study started on 2011-04. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01410136?
The interventions under investigation include: Chondrofix Osteochondral Allograft (PROCEDURE).
Who is sponsoring clinical trial NCT01410136?
This trial is sponsored by Zimmer Orthobiologics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.